Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TH3L
|
|||
| Drug Name |
PMID28092474-Compound-32q
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
KARUS THERAPEUTICS LTD
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H11F4N5O2S
|
|||
| Canonical SMILES |
C1=CC(=CC=C1CN(C2=NC=C(C=C2)F)C3=NC(=NS3)C(F)(F)F)C(=O)NO
|
|||
| InChI |
1S/C16H11F4N5O2S/c17-11-5-6-12(21-7-11)25(15-22-14(24-28-15)16(18,19)20)8-9-1-3-10(4-2-9)13(26)23-27/h1-7,27H,8H2,(H,23,26)
|
|||
| InChIKey |
XGHLBDLYNQPBIS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137).Expert Opin Ther Pat. 2017 Mar;27(3):229-236. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.